AbCellera Biologics
ABCL
ABCL
124 hedge funds and large institutions have $1.63B invested in AbCellera Biologics in 2021 Q4 according to their latest regulatory filings, with 33 funds opening new positions, 43 increasing their positions, 30 reducing their positions, and 25 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding in top 10
Funds holding in top 10: →
7% more funds holding
Funds holding: 116 → 124 (+8)
5.26% more ownership
Funds ownership: 35.41% → 40.68% (+5.3%)
18% less capital invested
Capital invested by funds: $1.98B → $1.63B (-$349M)
Holders
124
Holding in Top 10
9
Calls
$43.3M
Puts
$18.6M
Top Buyers
| 1 | +$31.9M | |
| 2 | +$19.9M | |
| 3 | +$19.2M | |
| 4 |
Capital International Investors
Los Angeles,
California
|
+$14.6M |
| 5 |
Royal Bank of Canada
Toronto,
Ontario, Canada
|
+$9.41M |
Top Sellers
| 1 | -$19.5M | |
| 2 | -$9.92M | |
| 3 | -$6.78M | |
| 4 |
E
Ergoteles
New York
|
-$6.64M |
| 5 |
Point72 Asset Management
Stamford,
Connecticut
|
-$5.47M |